Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 11
Therapeutics and Clinical Risk Management
ISSN: 1178-203X
- View all (2283)
- Volume 19, 2023 (66)
- Volume 18, 2022 (104)
- Volume 17, 2021 (134)
- Volume 16, 2020 (134)
- Volume 15, 2019 (154)
- Volume 14, 2018 (271)
- Volume 13, 2017 (188)
- Volume 12, 2016 (217)
- Volume 11, 2015 (210)
- Volume 10, 2014 (113)
- Volume 9, 2013 (57)
- Volume 8, 2012 (47)
- Volume 7, 2011 (59)
- Volume 6, 2010 (66)
- Volume 5, 2009 (102)
- Volume 4, 2008 (148)
- Volume 3, 2007 (126)
- Volume 2, 2006 (47)
- Volume 1, 2005 (40)
Archive: Volume 11, 2015
USP18 downregulation in peripheral blood mononuclear cells predicts nonresponse to interferon-based triple therapy in patients with chronic hepatitis C, genotype 1: a pilot study
Frankova S, Jirsa M, Merta D, Neroldova M, Urbanek P, Senkerikova R, Spicak J, Sperl J
Therapeutics and Clinical Risk Management 2015, 11:1853-1861
Published Date: 17 December 2015
Are atrophic long-bone nonunions associated with low-grade infections?
Dapunt U, Spranger O, Gantz S, Burckhardt I, Zimmermann S, Schmidmaier G, Moghaddam A
Therapeutics and Clinical Risk Management 2015, 11:1843-1852
Published Date: 15 December 2015
Enema reduction of intussusception: the success rate of hydrostatic and pneumatic reduction
Khorana J, Singhavejsakul J, Ukarapol N, Laohapensang M, Wakhanrittee J, Patumanond J
Therapeutics and Clinical Risk Management 2015, 11:1837-1842
Published Date: 15 December 2015
The effect of low-sodium dialysate on ambulatory blood pressure measurement parameters in patients undergoing hemodialysis
Akdag S, Akyol A, Cakmak HA, Tosu AR, Asker M, Yaman M, Babat N, Soyoral Y, Cegin MB, Gur AK, Gumrukcuoglu HA
Therapeutics and Clinical Risk Management 2015, 11:1829-1835
Published Date: 11 December 2015
Early myocardial damage assessment in dystrophinopathies using 99Tcm-MIBI gated myocardial perfusion imaging
Zhang L, Liu Z, Hu KY, Tian QB, Wei LG, Zhao Z, Shen HR, Hu J
Therapeutics and Clinical Risk Management 2015, 11:1819-1827
Published Date: 10 December 2015
Lung ultrasound for the diagnosis of childhood pneumonia: a safe and accurate imaging mode
Hendaus MA, Jomha FA, Alhammadi AH
Therapeutics and Clinical Risk Management 2015, 11:1817-1818
Published Date: 9 December 2015
Docetaxel-related interstitial pneumonitis
Wang CJ, Chang HT, Chang CY
Therapeutics and Clinical Risk Management 2015, 11:1813-1816
Published Date: 9 December 2015
Differential pharmacology and clinical utility of long-acting bronchodilators in COPD – focus on olodaterol
Matera MG, Ora J, Cazzola M
Therapeutics and Clinical Risk Management 2015, 11:1805-1811
Published Date: 4 December 2015
Scaling and root planning and locally delivered minocycline could reduce the load of Prevotella intermedia in an interdependent pattern, which correlated with symptomatic improvements of chronic periodontitis: a short-term randomized clinical trial
Deng S, Wang Y, Sun W, Chen H, Wu G
Therapeutics and Clinical Risk Management 2015, 11:1795-1803
Published Date: 4 December 2015
Medical devices for restless legs syndrome – clinical utility of the Relaxis pad
Mitchell UH
Therapeutics and Clinical Risk Management 2015, 11:1789-1794
Published Date: 3 December 2015
Hypercalcemia of malignancy and new treatment options
Sternlicht H, Glezerman IG
Therapeutics and Clinical Risk Management 2015, 11:1779-1788
Published Date: 4 December 2015
Profile of secukinumab in the treatment of psoriasis: current perspectives
Roman M, Madkan VK, Chiu MW
Therapeutics and Clinical Risk Management 2015, 11:1767-1777
Published Date: 2 December 2015
Bevacizumab for glioblastoma
Narita Y
Therapeutics and Clinical Risk Management 2015, 11:1759-1765
Published Date: 1 December 2015
Spotlight on rituximab in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis: current perspectives
Moog P, Thuermel K
Therapeutics and Clinical Risk Management 2015, 11:1749-1758
Published Date: 27 November 2015
The role of NOS2A -954G/C and vascular endothelial growth factor +936C/T polymorphisms in type 2 diabetes mellitus and diabetic nonproliferative retinopathy risk management
Porojan MD, Cătană A, Popp RA, Dumitrascu DL, Bala C
Therapeutics and Clinical Risk Management 2015, 11:1743-1748
Published Date: 27 November 2015
The limits of oral therapy in pulmonary arterial hypertension management
Liu QQ, Jing ZC
Therapeutics and Clinical Risk Management 2015, 11:1731-1741
Published Date: 23 November 2015
A case of Descemet’s membrane detachments and tears during phacoemulsification
Wang Y, Guan H
Therapeutics and Clinical Risk Management 2015, 11:1727-1729
Published Date: 19 November 2015
Long-term safety and efficacy of infliximab for the treatment of ankylosing spondylitis
Elalouf O, Elkayam O
Therapeutics and Clinical Risk Management 2015, 11:1719-1726
Published Date: 19 November 2015
Comparison between anterior cervical discectomy with fusion and anterior cervical corpectomy with fusion for the treatment of cervical spondylotic myelopathy: a meta-analysis
Fei Q, Li J, Su N, Wang B, Li D, Meng H, Wang Q, Lin J, Ma Z, Yang Y
Therapeutics and Clinical Risk Management 2015, 11:1707-1718
Published Date: 17 November 2015
Clinical development of nintedanib for advanced non-small-cell lung cancer
Takeda M, Okamoto I, Nakagawa K
Therapeutics and Clinical Risk Management 2015, 11:1701-1706
Published Date: 16 November 2015
Systemic spread of tuberculosis after surgery for a splenic tuberculous abscess without postoperational antituberculosis treatment: a case report
Yan D, Zhong CL, Li LJ
Therapeutics and Clinical Risk Management 2015, 11:1697-1700
Published Date: 11 November 2015
Evidence-based treatments for cluster headache
Gooriah R, Buture A, Ahmed F
Therapeutics and Clinical Risk Management 2015, 11:1687-1696
Published Date: 9 November 2015
Hemogram parameters for predicting pulmonary embolism in patients with deep venous thrombosis
Kaya H, Kurt R
Therapeutics and Clinical Risk Management 2015, 11:1683-1685
Published Date: 6 November 2015
Association of epicardial adipose tissue thickness and inflammation parameters with CHA2DS2-VASc score in patients with nonvalvular atrial fibrillation
Akdag S, Simsek H, Sahin M, Akyol A, Duz R, Babat N
Therapeutics and Clinical Risk Management 2015, 11:1675-1681
Published Date: 6 November 2015
Bortezomib in mantle cell lymphoma: comparative therapeutic outcomes
Vallumsetla N, Paludo J, Kapoor P
Therapeutics and Clinical Risk Management 2015, 11:1663-1674
Published Date: 6 November 2015
New developments in the management of schizophrenia and bipolar disorder: potential use of cariprazine
Werner FM, Coveñas R
Therapeutics and Clinical Risk Management 2015, 11:1657-1661
Published Date: 2 November 2015
Managing gastroesophageal reflux disease – comparative efficacy and outcomes of dexlansoprazole MR
Frye JW, Peura DA
Therapeutics and Clinical Risk Management 2015, 11:1649-1656
Published Date: 30 October 2015
The relationships between blood pressure, blood glucose, and bone mineral density in postmenopausal Turkish women
Cakmak HA, Cakmak BD, Yumru AE, Aslan S, Enhos A, Kalkan AK, Inci Coskun E, Acikgoz AS, Karatas S
Therapeutics and Clinical Risk Management 2015, 11:1641-1648
Published Date: 30 October 2015
Critical appraisal of extended-release hydrocodone for chronic pain: patient considerations
Gould HJ III, Paul D
Therapeutics and Clinical Risk Management 2015, 11:1635-1640
Published Date: 22 October 2015
Decompressive craniectomy for severe traumatic brain injury patients with fixed dilated pupils
Mao X, Miao G, Hao S, Tao X, Hou Z, Li H, Tian R, Zhang H, Lu T, Ma J, Zhang X, Cheng H, Liu B
Therapeutics and Clinical Risk Management 2015, 11:1627-1633
Published Date: 22 October 2015
Effect of fluid loading on left ventricular volume and stroke volume variability in patients with end-stage renal disease: a pilot study
Kanda H, Hirasaki Y, Iida T, Kanao-Kanda M, Toyama Y, Kunisawa T, Iwasaki H
Therapeutics and Clinical Risk Management 2015, 11:1619-1625
Published Date: 20 October 2015
The role of blood groups in the development of diabetes mellitus after gestational diabetes mellitus
Karagoz H, Erden A, Ozer O, Esmeray K, Cetinkaya A, Avci D, Karahan S, Basak M, Bulut K, Mutlu H, Simsek Y
Therapeutics and Clinical Risk Management 2015, 11:1613-1617
Published Date: 19 October 2015
Patterns of treatment and costs of intermediate and advanced hepatocellular carcinoma management in four Italian centers
Colombo GL, Cammà C, Attili AF, Ganga R, Gaeta GB, Brancaccio G, Franzini JM, Volpe M, Turchetti G
Therapeutics and Clinical Risk Management 2015, 11:1603-1612
Published Date: 19 October 2015
Symptomatic flexible flatfoot in adults: subtalar arthroereisis
Ozan F, Doğar F, Gençer K, Koyuncu Ş, Vatansever F, Duygulu F, Altay T
Therapeutics and Clinical Risk Management 2015, 11:1597-1602
Published Date: 16 October 2015
Feasibility of full and rapid neuromuscular blockade recovery with sugammadex in myasthenia gravis patients undergoing surgery – a series of 117 cases
Vymazal T, Krecmerova M, Bicek V, Lischke R
Therapeutics and Clinical Risk Management 2015, 11:1593-1596
Published Date: 15 October 2015
Mandibular bone mineral density in patients with Behçet’s disease
Asutay F, Atalay Y, Acar AH, Asutay H, Eroğlu S, Burdurlu MÇ
Therapeutics and Clinical Risk Management 2015, 11:1587-1591
Published Date: 14 October 2015
Hydrogen-rich saline may be an effective and specific novel treatment for osteoradionecrosis of the jaw
Chen Y, Zong C, Guo Y, Tian L
Therapeutics and Clinical Risk Management 2015, 11:1581-1585
Published Date: 14 October 2015
Successful administration of venovenous extracorporeal membrane oxygenation through the modified Blalock–Taussig operation in an infant with graft dysfunction after the Norwood procedure
Kanao-Kanda M, Kunisawa T, Yamamoto K, Kanda H, Iwasaki H
Therapeutics and Clinical Risk Management 2015, 11:1579-1580
Published Date: 13 October 2015
Pulse oximetry in bronchiolitis: is it needed?
Hendaus MA, Jomha FA, Alhammadi AH
Therapeutics and Clinical Risk Management 2015, 11:1573-1578
Published Date: 12 October 2015
Pharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPD
Pelaia G, Vatrella A, Busceti MT, Gallelli L, Calabrese C, Terracciano R, Lombardo N, Maselli R
Therapeutics and Clinical Risk Management 2015, 11:1563-1572
Published Date: 8 October 2015
Prognostic nutritional index before adjuvant chemotherapy predicts chemotherapy compliance and survival among patients with non-small-cell lung cancer
Shimizu K, Okita R, Saisho S, Yukawa T, Maeda A, Nojima Y, Nakata M
Therapeutics and Clinical Risk Management 2015, 11:1555-1561
Published Date: 8 October 2015
Comparison of efficacy of the intermittent pneumatic compression with a high- and low-pressure application in reducing the lower limbs phlebolymphedema
Taradaj J, Rosińczuk J, Dymarek R, Halski T, Schneider W
Therapeutics and Clinical Risk Management 2015, 11:1545-1554
Published Date: 7 October 2015
Cigarette smoke is a risk factor for severity and treatment outcome in patients with culture-positive tuberculosis
Chuang HC, Su CL, Liu HC, Feng PH, Lee KY, Chuang KJ, Lee CN, Bien MY
Therapeutics and Clinical Risk Management 2015, 11:1539-1544
Published Date: 6 October 2015
Study of ambulatory blood pressure in diabetic children: prediction of early renal insult
Shalaby NM, Shalaby NM
Therapeutics and Clinical Risk Management 2015, 11:1531-1537
Published Date: 5 October 2015
Acute gastrointestinal injury in the intensive care unit: a retrospective study
Chen HS, Zhang HD, Li W, Wu SN, Wang W
Therapeutics and Clinical Risk Management 2015, 11:1523-1529
Published Date: 5 October 2015
Anatomic and functional outcomes of retinectomy for the management of complicated retinal detachment with proliferative vitreoretinopathy
Tranos P, Vakalis A, Asteriadis S, Lokovitis E, Georgalas I, Stravrakas P
Therapeutics and Clinical Risk Management 2015, 11:1515-1521
Published Date: 3 October 2015
The potential of medical device industry in technological and economical context
Maresova P, Penhaker M, Selamat A, Kuca K
Therapeutics and Clinical Risk Management 2015, 11:1505-1514
Published Date: 3 October 2015
Surveillance of antibiotic and analgesic use in the Oral Surgery Department of the University Dentistry Clinical Center of Kosovo
Haliti NR, Haliti FR, Koçani FK, Gashi AA, Mrasori SI, Hyseni VI, Bytyqi SI, Krasniqi LL, Murtezani AF, Krasniqi SL
Therapeutics and Clinical Risk Management 2015, 11:1497-1503
Published Date: 1 October 2015
Analysis of the incidence of postintubation injuries in patients intubated in the prehospital or early hospital conditions of the hospital emergency department and the intensive care unit
Cierniak M, Timler D, Sobczak R, Wieczorek A, Sekalski P, Borkowska N, Gaszynski T
Therapeutics and Clinical Risk Management 2015, 11:1489-1496
Published Date: 1 October 2015
Assessment and management of respiratory function in patients with Duchenne muscular dystrophy: current and emerging options
LoMauro A, D’Angelo MG, Aliverti A
Therapeutics and Clinical Risk Management 2015, 11:1475-1488
Published Date: 28 September 2015
Bivalirudin plus loading dose of cilostazol-based triple-antiplatelet in treatment of non-ST-elevation myocardial infarction following percutaneous coronary intervention
Wang M, Zhang GR, Wang YL, Zhou K, Liu T, Zhang Y, Guo AJ, An Y, Zhang XD, Li YJ
Therapeutics and Clinical Risk Management 2015, 11:1469-1473
Published Date: 28 September 2015
Emerging therapeutic options for sporadic inclusion body myositis
Alfano LN, Lowes LP
Therapeutics and Clinical Risk Management 2015, 11:1459-1467
Published Date: 25 September 2015
Diagnosis and management of miliary tuberculosis: current state and future perspectives [Retraction]
Ray S, Talukdar A, Kundu S, Khanra D, Sonthalia N
Therapeutics and Clinical Risk Management 2015, 11:1457-1458
Published Date: 28 September 2015
New insights into the mechanisms of action of aspirin and its use in the prevention and treatment of arterial and venous thromboembolism
Mekaj YH, Daci FT, Mekaj AY
Therapeutics and Clinical Risk Management 2015, 11:1449-1456
Published Date: 24 September 2015
Comparison of zero-profile anchored spacer versus plate-cage construct in treatment of cervical spondylosis with regard to clinical outcomes and incidence of major complications: a meta-analysis
Liu WJ, Hu L, Wang JW, Liu M, Wang XM
Therapeutics and Clinical Risk Management 2015, 11:1437-1447
Published Date: 23 September 2015
Tumor necrosis factor-alpha G-238A polymorphism and coronary artery disease risk: a meta-analysis of 4,222 patients and 4,832 controls
Hua XP, Zhang XD, Kwong JS, Zeng XT, Zhang ZJ, Wei WL
Therapeutics and Clinical Risk Management 2015, 11:1429-1436
Published Date: 23 September 2015
Optimizing clopidogrel dose response: a new clinical algorithm comprising CYP2C19 pharmacogenetics and drug interactions
Saab YB, Zeenny R, Ramadan WH
Therapeutics and Clinical Risk Management 2015, 11:1421-1427
Published Date: 23 September 2015
The clinical application of linagliptin in Asians
Cao CQ, Xiang YF, Zhou ZG
Therapeutics and Clinical Risk Management 2015, 11:1409-1419
Published Date: 16 September 2015
Association between ambient carbon monoxide and secondary hyperparathyroidism in nondiabetic patients undergoing peritoneal dialysis
Weng CH, Hu CC, Yen TH, Huang WH
Therapeutics and Clinical Risk Management 2015, 11:1401-1408
Published Date: 16 September 2015
New advances in the treatment of generalized lipodystrophy: role of metreleptin
Rodriguez AJ, Mastronardi CA, Paz-Filho GJ
Therapeutics and Clinical Risk Management 2015, 11:1391-1400
Published Date: 16 September 2015
Perioperative management of hemophilia patients receiving total hip and knee arthroplasty: a complication report of two cases
Tateiwa T, Takahashi Y, Ishida T, Kubo K, Masaoka T, Shishido T, Sano K, Yamamoto K
Therapeutics and Clinical Risk Management 2015, 11:1383-1389
Published Date: 15 September 2015
Aldehyde dehydrogenase-2 protects against myocardial infarction-related cardiac fibrosis through modulation of the Wnt/β-catenin signaling pathway
Zhao XJ, Hua Y, Chen HM, Yang HY, Zhang T, Huang GQ, Fan HJ, Tan ZB, Huang XF, Liu B, Zhou YC
Therapeutics and Clinical Risk Management 2015, 11:1371-1381
Published Date: 11 September 2015
The hepatitis B virus reactivation after transarterial chemoembolization in Chinese hepatocellular carcinoma patients with low serum hepatitis B virus DNA level
Shao W, Zhang F, Cong N, Li J, Song J
Therapeutics and Clinical Risk Management 2015, 11:1367-1370
Published Date: 7 September 2015
A case series of pregnancy- and lactation-associated osteoporosis and a review of the literature
Nakamura Y, Kamimura M, Ikegami S, Mukaiyama K, Komatsu M, Uchiyama S, Kato H
Therapeutics and Clinical Risk Management 2015, 11:1361-1365
Published Date: 7 September 2015
Real-world analysis of the Celgene Global Drug Safety database: early discontinuation of lenalidomide in patients with myelodysplastic syndromes due to non-serious rash
Weiss L, Gary D, Swern AS, Freeman J, Sugrue MM
Therapeutics and Clinical Risk Management 2015, 11:1355-1360
Published Date: 4 September 2015
Efficacy and safety of metformin or oral contraceptives, or both in polycystic ovary syndrome
Yang YM, Choi EJ
Therapeutics and Clinical Risk Management 2015, 11:1345-1353
Published Date: 1 September 2015
The role of SDF-1/CXCR4 in the vasculogenesis and remodeling of cerebral arteriovenous malformation
Wang L, Guo S, Zhang N, Tao Y, Zhang H, Qi T, Liang F, Huang Z
Therapeutics and Clinical Risk Management 2015, 11:1337-1344
Published Date: 1 September 2015
Efficacy of biological agents administered as monotherapy in rheumatoid arthritis: a Bayesian mixed-treatment comparison analysis
Migliore A, Bizzi E, Egan CG, Bernardi M, Petrella L
Therapeutics and Clinical Risk Management 2015, 11:1325-1335
Published Date: 1 September 2015
Cancer risk in patients aged 30 years and above with type 2 diabetes receiving antidiabetic monotherapy: a cohort study using metformin as the comparator
Chen YC, Kok VC, Chien CH, Horng JT, Tsai JJ
Therapeutics and Clinical Risk Management 2015, 11:1315-1323
Published Date: 28 August 2015
National consumption of opioid and nonopioid analgesics in Croatia: 2007–2013
Krnic D, Anic-Matic A, Dosenovic S, Draganic P, Zezelic S, Puljak L
Therapeutics and Clinical Risk Management 2015, 11:1305-1314
Published Date: 28 August 2015
Validity of subjective smoking status in orthopedic patients
Bender D, Haubruck P, Boxriker S, Korff S, Schmidmaier G, Moghaddam A
Therapeutics and Clinical Risk Management 2015, 11:1297-1303
Published Date: 27 August 2015
Tracheobronchial foreign bodies in children – a retrospective study of 2,000 cases in Northwestern China
Liang JM, Hu J, Chang HM, Gao Y, Luo HN, Wang ZH, Zheng GX, Chen F, Wang T, Yang YY, Kou XH, Xu M
Therapeutics and Clinical Risk Management 2015, 11:1291-1295
Published Date: 28 August 2015
Serotonin reuptake inhibitors and post-gastrostomy bleeding: reevaluating the link
Patel H, Gaduputi V, Sakam S, Kumar K, Chime C, Balar B
Therapeutics and Clinical Risk Management 2015, 11:1283-1289
Published Date: 27 August 2015
Apixaban for the prophylaxis and treatment of deep vein thrombosis and pulmonary embolism: an evidence-based review
Mandernach MW, Beyth RJ, Rajasekhar A
Therapeutics and Clinical Risk Management 2015, 11:1273-1282
Published Date: 26 August 2015
Virus-induced secondary bacterial infection: a concise review
Hendaus MA, Jomha FA, Alhammadi AH
Therapeutics and Clinical Risk Management 2015, 11:1265-1271
Published Date: 24 August 2015
CD226 gene polymorphisms are associated with non-small-cell lung cancer in the Chinese Han population
Qiu ZX, Peng Y, Li WM
Therapeutics and Clinical Risk Management 2015, 11:1259-1264
Published Date: 24 August 2015
Predictors of mortality in solid-organ transplant recipients with infections caused by Acinetobacter baumannii
Liu H, Ye QF, Wan QQ, Zhou JD
Therapeutics and Clinical Risk Management 2015, 11:1251-1257
Published Date: 21 August 2015
Value of serial platelet indices measurements for the prediction of pulmonary embolism in patients with deep venous thrombosis
Sevuk U, Bahadir MV, Altindag R, Baysal E, Yaylak B, Ay N, Ayaz F, Demirtas E
Therapeutics and Clinical Risk Management 2015, 11:1243-1249
Published Date: 20 August 2015
Patient considerations in the management of ulcerative colitis – role of vedolizumab
Kothari M, Mudireddy P, Swaminath A
Therapeutics and Clinical Risk Management 2015, 11:1235-1242
Published Date: 19 August 2015
Pulmonary hypertension: diagnostic and therapeutic challenges
Bazan IS, Fares WH
Therapeutics and Clinical Risk Management 2015, 11:1221-1233
Published Date: 17 August 2015
Appendectomy in a child with cyclic neutropenia in profound neutropenic episode
Glavan N, Roganović J, Glavan-Gačanin L, Jonjić N
Therapeutics and Clinical Risk Management 2015, 11:1217-1219
Published Date: 17 August 2015
Comparison of outcomes of laparoscopic intracorporeal knotting technique in patients with complicated and noncomplicated acute appendicitis
Ay N, Dinç B, Alp V, Kaya S, Sevük U
Therapeutics and Clinical Risk Management 2015, 11:1213-1216
Published Date: 12 August 2015
Profile of vortioxetine in the treatment of major depressive disorder: an overview of the primary and secondary literature
Kelliny M, Croarkin PE, Moore KM, Bobo WV
Therapeutics and Clinical Risk Management 2015, 11:1193-1212
Published Date: 12 August 2015
The relationship between eosinophilia and slow coronary flow
Altas Y, Kurtoglu E, Yaylak B, Baysal E, Ucaman B, Ugurlu HM, Karahan MZ, Altintas B, Adiyaman MS, Kaya İ, Erdolu U, Ozen K, Cakir C, Sevuk U
Therapeutics and Clinical Risk Management 2015, 11:1187-1191
Published Date: 12 August 2015
Intern doctors’ views on the current and future antibiotic resistance situation of Chattagram Maa O Shishu Hospital Medical College, Bangladesh
Hoque R, Mostafa A, Haque M
Therapeutics and Clinical Risk Management 2015, 11:1177-1185
Published Date: 11 August 2015
A review of the clinical utility of duloxetine in the treatment of diabetic peripheral neuropathic pain
King JB, Schauerhamer MB, Bellows BK
Therapeutics and Clinical Risk Management 2015, 11:1163-1175
Published Date: 10 August 2015
Exenatide once-weekly injection for the treatment of type 2 diabetes in Chinese patients: current perspectives
Deng W, Qiu S, Yang G, Chen B
Therapeutics and Clinical Risk Management 2015, 11:1153-1162
Published Date: 10 August 2015
Xerostomia induced by radiotherapy
Alimi D
Therapeutics and Clinical Risk Management 2015, 11:1149-1152
Published Date: 5 August 2015
The appropriate troponin T level associated with coronary occlusions in chronic kidney disease patients
Sittichanbuncha Y, Sricharoen P, Tangkulpanich P, Sawanyawisuth K
Therapeutics and Clinical Risk Management 2015, 11:1143-1147
Published Date: 4 August 2015
Cesarean scar pregnancy treated by curettage and aspiration guided by laparoscopy
Shu S, Luo X, Wang Z, Yao Y
Therapeutics and Clinical Risk Management 2015, 11:1139-1141
Published Date: 3 August 2015
Clinical potential of vorapaxar in cardiovascular risk reduction in patients with atherosclerosis
Diehl P, Bode C, Duerschmied D
Therapeutics and Clinical Risk Management 2015, 11:1133-1138
Published Date: 3 August 2015
Critical evaluation of ramucirumab in the treatment of advanced gastric and gastroesophageal cancers
ElHalawani H, Abdel-Rahman O
Therapeutics and Clinical Risk Management 2015, 11:1123-1132
Published Date: 28 July 2015
New developments in the treatment of chronic lymphocytic leukemia: role of obinutuzumab
Shah A
Therapeutics and Clinical Risk Management 2015, 11:1113-1122
Published Date: 28 July 2015
Massive hemorrhage management – a best evidence topic report
Vymazal T
Therapeutics and Clinical Risk Management 2015, 11:1107-1111
Published Date: 27 July 2015
Fluid accumulation threshold measured by acute body weight change after admission in general surgical intensive care units: how much should be concerning?
Chittawatanarat K, Pichaiya T, Chandacham K, Jirapongchareonlap T, Chotirosniramit N
Therapeutics and Clinical Risk Management 2015, 11:1097-1106
Published Date: 27 July 2015
Paclitaxel reduces formation of hypertrophic scars in the rabbit ear model
Huang LP, Wang GQ, Jia ZS, Chen JW, Wang G, Wang XL
Therapeutics and Clinical Risk Management 2015, 11:1089-1095
Published Date: 27 July 2015
Treatment of degloving injury involving multiple fingers with combined abdominal superficial fascial flap, dorsalis pedis flap, dorsal toe flap, and toe-web flap
Han F, Wang G, Li G, Ping J, Mao Z
Therapeutics and Clinical Risk Management 2015, 11:1081-1087
Published Date: 23 July 2015
Transmural dispersion of repolarization and atrial electromechanical coupling: complementary indices for quantifying cardiac electrical heterogeneity in patients with conversion disorder
Tokatli A, Yiginer O, Degirmencioglu G, Kilicaslan F, Uzun M
Therapeutics and Clinical Risk Management 2015, 11:1077-1080
Published Date: 20 July 2015
Adverse drug reactions and drug–drug interactions with over-the-counter NSAIDs
Moore N, Pollack C, Butkerait P
Therapeutics and Clinical Risk Management 2015, 11:1061-1075
Published Date: 15 July 2015
Vasopressors in septic shock: a systematic review and network meta-analysis
Zhou FH, Mao Z, Zeng XT, Kang HJ, Liu H, Pan L, Hou PC
Therapeutics and Clinical Risk Management 2015, 11:1047-1059
Published Date: 14 July 2015
Which people should take aspirin for primary prevention of cardiovascular disease?
Lozano R, Franco ME
Therapeutics and Clinical Risk Management 2015, 11:1043-1045
Published Date: 2 July 2015
Adverse reaction to ceftriaxone in a 28-day-old infant undergoing urgent craniotomy due to epidural hematoma: review of neonatal biliary pseudolithiasis
Bartkowska-Śniatkowska A, Jończyk-Potoczna K, Zielińska M, Rosada-Kurasińska J
Therapeutics and Clinical Risk Management 2015, 11:1035-1041
Published Date: 2 July 2015
Presepsin as a diagnostic marker for sepsis: evidence from a bivariate meta-analysis
Tong X, Cao Y, Yu M, Han C
Therapeutics and Clinical Risk Management 2015, 11:1027-1033
Published Date: 2 July 2015
Comparative study on drug safety surveillance between medical students of Malaysia and Nigeria
Abubakar AR, Ismail S, Rahman NIA, Haque M
Therapeutics and Clinical Risk Management 2015, 11:1015-1025
Published Date: 30 June 2015
OnabotulinumtoxinA for chronic migraine: a critical appraisal
Gooriah R, Ahmed F
Therapeutics and Clinical Risk Management 2015, 11:1003-1013
Published Date: 29 June 2015
Managing infertility with the follitropin alfa prefilled pen injector – patient considerations
Bühler K
Therapeutics and Clinical Risk Management 2015, 11:995-1001
Published Date: 29 June 2015
Canagliflozin-induced pancreatitis: a rare side effect of a new drug
Chowdhary M, Kabbani AA, Chhabra A
Therapeutics and Clinical Risk Management 2015, 11:991-994
Published Date: 26 June 2015
A critical appraisal of ibrutinib in the treatment of mantle cell lymphoma and chronic lymphocytic leukemia
Tucker DL, Rule SA
Therapeutics and Clinical Risk Management 2015, 11:979-990
Published Date: 23 June 2015
New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events
Mekaj YH, Mekaj AY, Duci SB, Miftari EI
Therapeutics and Clinical Risk Management 2015, 11:967-977
Published Date: 24 June 2015
Boussignac CPAP system for brain death confirmation with apneic test in case of acute lung injury/adult respiratory distress syndrome – series of cases
Wieczorek A, Gaszynski T
Therapeutics and Clinical Risk Management 2015, 11:961-965
Published Date: 17 June 2015
Circulating thymus and activation-regulated chemokine/CC chemokine ligand 17 is a strong candidate diagnostic marker for interstitial lung disease in patients with malignant tumors: a result from a pilot study
Yamane H, Ochi N, Yamagishi T, Honda Y, Takeyama M, Takigawa N
Therapeutics and Clinical Risk Management 2015, 11:949-959
Published Date: 17 June 2015
Optimal management of digital ulcers in systemic sclerosis
Abraham S, Steen V
Therapeutics and Clinical Risk Management 2015, 11:939-947
Published Date: 15 June 2015
Staphylococcus aureus bacteremias following liver transplantation: a clinical analysis of 20 cases
Zhou JD, Huang H, Liu S, Yu P, Wan QQ
Therapeutics and Clinical Risk Management 2015, 11:933-937
Published Date: 12 June 2015
Management of epilepsy in patients with Rett syndrome: perspectives and considerations
Krajnc N
Therapeutics and Clinical Risk Management 2015, 11:925-932
Published Date: 10 June 2015
Neurogenic orthostatic hypotension – management update and role of droxidopa
Vijayan J, Sharma VK
Therapeutics and Clinical Risk Management 2015, 11:915-923
Published Date: 8 June 2015
Comprehensive overview: efficacy, tolerability, and cost-effectiveness of clobazam in Lennox–Gastaut syndrome
Faulkner MA
Therapeutics and Clinical Risk Management 2015, 11:905-914
Published Date: 8 June 2015
GLP-1 reduces metalloproteinase-9 induced by both hyperglycemia and hypoglycemia in type 1 diabetes. The possible role of oxidative stress
Ceriello A, La Sala L, De Nigris V, Pujadas G, Rondinelli M, Genovese S
Therapeutics and Clinical Risk Management 2015, 11:901-903
Published Date: 4 June 2015
Fluticasone-formoterol: a systematic review of its potential role in the treatment of asthma
Prosser TR, Bollmeier SG
Therapeutics and Clinical Risk Management 2015, 11:889-899
Published Date: 2 June 2015
Two cases of Paget’s disease of scrotum in biological brothers
Rao D, Zhu H, Yu K, Yu H, Xie L
Therapeutics and Clinical Risk Management 2015, 11:885-887
Published Date: 27 May 2015
Novel targeted therapies in chordoma: an update
Di Maio S, Yip S, Al Zhrani GA, Alotaibi FE, Al Turki A, Kong E, Rostomily R
Therapeutics and Clinical Risk Management 2015, 11:873-883
Published Date: 26 May 2015
The incidence and risk factors of peripherally inserted central catheter-related infection among cancer patients
Gao Y, Liu Y, Ma X, Wei L, Chen W, Song L
Therapeutics and Clinical Risk Management 2015, 11:863-871
Published Date: 22 May 2015
New developments in the management of severe skin and deep skin structure infections – focus on tedizolid
Durkin MJ, Corey GR
Therapeutics and Clinical Risk Management 2015, 11:857-862
Published Date: 22 May 2015
Residual disease and risk factors in patients with high-grade cervical intraepithelial neoplasia and positive margins after initial conization
Fu Y, Chen C, Feng S, Cheng X, Wang X, Xie X, Lü W
Therapeutics and Clinical Risk Management 2015, 11:851-856
Published Date: 21 May 2015
Transtracheal single-point stent fixation in posttracheotomy tracheomalacia under cone-beam computer tomography guidance by transmural suturing with the Berci needle – a perspective on a new tool to avoid stent migration of Dumon stents
Hohenforst-Schmidt W, Linsmeier B, Zarogoulidis P,Freitag L, Darwiche K, Browning R, Turner JF, Huang H, Li Q, Vogl T, Zarogoulidis K, Brachmann J, Rittger H
Therapeutics and Clinical Risk Management 2015, 11:837-850
Published Date: 22 May 2015
Functional and histological improvement after everolimus rescue of chronic allograft dysfunction in renal transplant recipients
Chow KM, Szeto CC, Lai FM, Luk CC, Kwan BC, Leung CB, Li PK
Therapeutics and Clinical Risk Management 2015, 11:829-835
Published Date: 19 May 2015
Association of low potassium diet and folic acid deficiency in patients with CKD
Hassan K
Therapeutics and Clinical Risk Management 2015, 11:821-827
Published Date: 18 May 2015
Marketed nonsteroidal anti-inflammatory agents, antihypertensives, and human immunodeficiency virus protease inhibitors: as-yet-unused weapons of the oncologists’ arsenal
Papanagnou P, Baltopoulos P, Tsironi M
Therapeutics and Clinical Risk Management 2015, 11:807-819
Published Date: 18 May 2015
Management of patients with type 2 diabetes and mild/moderate renal impairment: profile of linagliptin
Gallwitz B
Therapeutics and Clinical Risk Management 2015, 11:799-805
Published Date: 14 May 2015
Testosterone levels of children with a diagnosis of developmental stuttering
Selçuk EB, Erbay LG, Özcan ÖÖ, Kartalcı S, Batcıoğlu K
Therapeutics and Clinical Risk Management 2015, 11:793-798
Published Date: 14 May 2015
The role of delamanid in the treatment of drug-resistant tuberculosis
Lewis JM, Sloan DJ
Therapeutics and Clinical Risk Management 2015, 11:779-791
Published Date: 13 May 2015
To what extent is clinical and laboratory information used to perform medication reviews in the nursing home setting? the CLEAR study
Mestres Gonzalvo C, Hurkens KPGM, de Wit HAJM, van Oijen BPC, Janknegt R, Schols JMGA, Mulder WJ, Verhey FR, Winkens B, van der Kuy PHM
Therapeutics and Clinical Risk Management 2015, 11:767-777
Published Date: 8 May 2015
Profile of PEGylated interferon beta in the treatment of relapsing-remitting multiple sclerosis
Cocco E, Marrosu MG
Therapeutics and Clinical Risk Management 2015, 11:759-766
Published Date: 8 May 2015
Refractory cachexia is associated with increased plasma concentrations of fentanyl in cancer patients
Suno M, Endo Y, Nishie H, Kajizono M, Sendo T, Matsuoka J
Therapeutics and Clinical Risk Management 2015, 11:751-757
Published Date: 8 May 2015
The role of empagliflozin in the management of type 2 diabetes by patient profile
Hedrington MS, Davis SN
Therapeutics and Clinical Risk Management 2015, 11:739-749
Published Date: 5 May 2015
Recurrent respiratory papillomatosis: current and future perspectives
Carifi M, Napolitano D, Morandi M, Dall’Olio D
Therapeutics and Clinical Risk Management 2015, 11:731-738
Published Date: 5 May 2015
Update on the management of chemotherapy-induced nausea and vomiting – focus on palonosetron
Zhou M, Popovic M, Pasetka M, Pulenzas N, Ahrari S, Chow E, DeAngelis C
Therapeutics and Clinical Risk Management 2015, 11:713-729
Published Date: 5 May 2015
Practical use of sevelamer in chronic kidney disease patients on dialysis in People’s Republic of China
Meng L, Fu B
Therapeutics and Clinical Risk Management 2015, 11:705-712
Published Date: 30 April 2015
Optimal management of constipation associated with irritable bowel syndrome
Furnari M, de Bortoli N, Martinucci I, Bodini G, Revelli M, Marabotto E, Moscatelli A, Del Nero L, Savarino E, Giannini EG, Savarino V
Therapeutics and Clinical Risk Management 2015, 11:691-703
Published Date: 30 April 2015
Serous macular detachment, yellow macular deposits, and prominent middle limiting membrane in multiple myeloma
Dogan B, Erol MK, Toslak D, Coban DT, Bulut M, Cengiz A, Sarı ES
Therapeutics and Clinical Risk Management 2015, 11:683-689
Published Date: 30 April 2015
Association of diabetes-related distress, depression, medication adherence, and health-related quality of life with glycated hemoglobin, blood pressure, and lipids in adult patients with type 2 diabetes: a cross-sectional study
Chew BH, Sherina MS, Hassan NH
Therapeutics and Clinical Risk Management 2015, 11:669-681
Published Date: 29 April 2015
Low-density lipoprotein cholesterol of less than 70 mg/dL is associated with fewer cardiovascular events in acute coronary syndrome patients: a real-life cohort in Thailand
Chinwong D, Patumanond J, Chinwong S, Siriwattana K, Gunaparn S, Hall JJ, Phrommintikul A
Therapeutics and Clinical Risk Management 2015, 11:659-667
Published Date: 24 April 2015
Evaluation of costs accrued through inadvertent continuation of hospital-initiated proton pump inhibitor therapy for stress ulcer prophylaxis beyond hospital discharge: a retrospective chart review
Shin S
Therapeutics and Clinical Risk Management 2015, 11:649-657
Published Date: 24 April 2015
Evaluation of the appropriate use of commonly prescribed fluoroquinolones and the risk of dysglycemia
Kabbara WK, Ramadan WH, Rahbany P, Al-Natour S
Therapeutics and Clinical Risk Management 2015, 11:639-647
Published Date: 22 April 2015
A novel missense KIT mutation causing piebaldism in one Chinese family associated with café-au-lait macules and intertriginous freckling
Jia WX, Xiao XM, Wu JB, Ma YP, Ge YP, Li Q, Mao QX, Li CR
Therapeutics and Clinical Risk Management 2015, 11:635-638
Published Date: 21 April 2015
Travel advice for the immunocompromised traveler: prophylaxis, vaccination, and other preventive measures [Corrigendum]
Patel RR, Liang SY, Koolwal P, Kuhlmann FM
Therapeutics and Clinical Risk Management 2015, 11:633-634
Published Date: 20 April 2015
Continual evolution of type 2 diabetes: an update on pathophysiology and emerging treatment options
Cornell S
Therapeutics and Clinical Risk Management 2015, 11:621-632
Published Date: 16 April 2015
Adalimumab in the management of Behçet’s disease
Ueda A, Takeno M, Ishigatsubo Y
Therapeutics and Clinical Risk Management 2015, 11:611-619
Published Date: 13 April 2015
Update on the emerging role of telavancin in hospital-acquired infections
Nnedu ON, Pankey GA
Therapeutics and Clinical Risk Management 2015, 11:605-610
Published Date: 13 April 2015
A randomized crossover study comparing trehalose/hyaluronate eyedrops and standard treatment: patient satisfaction in the treatment of dry eye syndrome
Pinto-Bonilla JC, del Olmo-Jimeno A, Llovet-Osuna F, Hernández-Galilea E
Therapeutics and Clinical Risk Management 2015, 11:595-603
Published Date: 13 April 2015
Copeptin: a new predictor for severe obstructive sleep apnea
Çınarka H, Kayhan S, Karataş M, Yavuz A, Gümüş A, Özyurt S, Cüre MC, Şahin Ü
Therapeutics and Clinical Risk Management 2015, 11:589-594
Published Date: 10 April 2015
Pneumoscrotum: report of two different cases and review of the literature
Cochetti G, Barillaro F, Cottini E, D’Amico F, Pansadoro A, Pohja S, Boni A, Cirocchi R, Grassi V, Mancuso R, Silvi E, Ioannidou K, Egidi MG, Poli G, Mearini E
Therapeutics and Clinical Risk Management 2015, 11:581-587
Published Date: 9 April 2015
Ceftaroline in the management of complicated skin and soft tissue infections and community acquired pneumonia
Mpenge MA, MacGowan AP
Therapeutics and Clinical Risk Management 2015, 11:565-579
Published Date: 7 April 2015
Ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia in the intensive care unit
Maggiore C, Vazquez JA, Guervil DJ, Ramani A, Jandourek A, Cole P, Friedland HD
Therapeutics and Clinical Risk Management 2015, 11:557-563
Published Date: 2 April 2015
Profile of pomalidomide and its potential in the treatment of myelofibrosis
Gowin KL, Mesa RA
Therapeutics and Clinical Risk Management 2015, 11:549-556
Published Date: 2 April 2015
Prostanoid therapies in the management of pulmonary arterial hypertension
LeVarge BL
Therapeutics and Clinical Risk Management 2015, 11:535-547
Published Date: 31 March 2015
Alemtuzumab for the treatment of multiple sclerosis
Willis MD, Robertson NP
Therapeutics and Clinical Risk Management 2015, 11:525-534
Published Date: 31 March 2015
The unsolved case of “bone-impairing analgesics”: the endocrine effects of opioids on bone metabolism
Coluzzi F, Pergolizzi J, Raffa RB, Mattia C
Therapeutics and Clinical Risk Management 2015, 11:515-523
Published Date: 31 March 2015
Combination of tadalafil and finasteride for improving the symptoms of benign prostatic hyperplasia: critical appraisal and patient focus
Elkelany OO, Owen RC, Kim ED
Therapeutics and Clinical Risk Management 2015, 11:507-513
Published Date: 30 March 2015
Distribution and resistance of pathogens in liver transplant recipients with Acinetobacter baumannii infection
Gao F, Ye QF, Wan QQ, Liu S, Zhou JD
Therapeutics and Clinical Risk Management 2015, 11:501-505
Published Date: 26 March 2015
Regular inhaled corticosteroids in adult-onset asthma and the risk for future cancer: a population-based cohort study with proper person-time analysis
Kok VC, Horng JT, Huang HK, Chao TM, Hong YF
Therapeutics and Clinical Risk Management 2015, 11:489-499
Published Date: 26 March 2015
Umeclidinium bromide/vilanterol combination in the treatment of chronic obstructive pulmonary disease: a review
Spyratos D, Sichletidis L
Therapeutics and Clinical Risk Management 2015, 11:481-487
Published Date: 25 March 2015
P-wave and QT dispersion in patients with conversion disorder
Izci F, Hocagil H, Izci S, Izci V, Koc MI, Acar RD
Therapeutics and Clinical Risk Management 2015, 11:475-480
Published Date: 26 March 2015
Ranolazine versus placebo in patients with ischemic cardiomyopathy and persistent chest pain or dyspnea despite optimal medical and revascularization therapy: randomized, double-blind crossover pilot study
Shammas NW, Shammas GA, Keyes K, Duske S, Kelly R, Jerin M
Therapeutics and Clinical Risk Management 2015, 11:469-474
Published Date: 23 March 2015
Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapy
Wang ZY, Chen M, Zhu LL, Yu LS, Zeng S, Xiang MX, Zhou Q
Therapeutics and Clinical Risk Management 2015, 11:449-467
Published Date: 19 March 2015
Epidemiology of Japanese encephalitis: past, present, and future prospects
Wang H, Liang G
Therapeutics and Clinical Risk Management 2015, 11:435-448
Published Date: 19 March 2015
Clinical use of pasireotide for Cushing's disease in adults
Ceccato F, Scaroni C, Boscaro M
Therapeutics and Clinical Risk Management 2015, 11:425-434
Published Date: 17 March 2015
Genotypic resistance profiles in Chinese patients with chronic hepatitis B virus infection and the efficacy of nucleoside analog rescue therapy
Liang LB, Chen LL, Chen EQ, Liao J, Tang H
Therapeutics and Clinical Risk Management 2015, 11:417-423
Published Date: 12 March 2015
Long-term safety and efficacy of tobramycin in the management of cystic fibrosis
Vázquez-Espinosa E, Girón RM, Gómez-Púnter RM, García-Castillo E, Valenzuela C, Cisneros C, Zamora E, García-Pérez FJ, Ancochea J
Therapeutics and Clinical Risk Management 2015, 11:407-415
Published Date: 12 March 2015
Quality improvements in decreasing medication administration errors made by nursing staff in an academic medical center hospital: a trend analysis during the journey to Joint Commission International accreditation and in the post-accreditation era
Wang HF, Jin JF, Feng XQ, Huang X, Zhu LL, Zhao XY, Zhou Q
Therapeutics and Clinical Risk Management 2015, 11:393-406
Published Date: 5 March 2015
Risk factors for osteoporosis in Japan: is it associated with Helicobacter pylori?
Asaoka D, Nagahara A, Shimada Y, Matsumoto K, Ueyama H, Matsumoto K, Nakagawa Y, Takeda T, Tanaka I, Sasaki H, Osada T, Hojo M, Watanabe S
Therapeutics and Clinical Risk Management 2015, 11:381-391
Published Date: 6 March 2015
Therapeutic effect of hybrid training of voluntary and electrical muscle contractions in middle-aged obese women with nonalcoholic fatty liver disease: a pilot trial
Oh S, Maruyama T, Eguchi K, Shida T, Arai E, Isobe T, Okamoto Y, Shoda J
Therapeutics and Clinical Risk Management 2015, 11:371-380
Published Date: 4 March 2015
Update on therapeutic management of idiopathic pulmonary fibrosis
Tzouvelekis A, Bonella F, Spagnolo P
Therapeutics and Clinical Risk Management 2015, 11:359-370
Published Date: 3 March 2015
Risk of breast cancer recurrence in patients receiving manual lymphatic drainage: a hospital-based cohort study
Hsiao PC, Liu JT, Lin CL, Chou W, Lu SR
Therapeutics and Clinical Risk Management 2015, 11:349-358
Published Date: 27 February 2015
Integrating risk minimization planning throughout the clinical development and commercialization lifecycle: an opinion on how drug development could be improved
Morrato EH, Smith MY
Therapeutics and Clinical Risk Management 2015, 11:339-348
Published Date: 26 February 2015
Management of chronic hepatitis C virus infection in patients with end-stage renal disease: a review
Aguirre Valadez J, García Juárez I, Rincón Pedrero R, Torre A
Therapeutics and Clinical Risk Management 2015, 11:329-338
Published Date: 27 February 2015
Role of physiotherapy and patient education in lymphedema control following breast cancer surgery
Lu SR, Hong RB, Chou W, Hsiao PC
Therapeutics and Clinical Risk Management 2015, 11:319-327
Published Date: 25 February 2015
Clinical use of azelnidipine in the treatment of hypertension in Chinese patients
Chen BL, Zhang YZ, Luo JQ, Zhang W
Therapeutics and Clinical Risk Management 2015, 11:309-318
Published Date: 24 February 2015
Optimal management of Ménière’s disease
Foster CA
Therapeutics and Clinical Risk Management 2015, 11:301-307
Published Date: 25 February 2015
Advances in diagnosis and treatment of trigeminal neuralgia
Montano N, Conforti G, Di Bonaventura R, Meglio M, Fernandez E, Papacci F
Therapeutics and Clinical Risk Management 2015, 11:289-299
Published Date: 24 February 2015
Effect of vitamin D therapy on interleukin-6, visfatin, and hyaluronic acid levels in chronic hepatitis C Egyptian patients
Sabry D, Al-Ghussein MAS, Hamdy G, Abul-Fotouh A, Motawi T, El Kazaz AY, Eldemery A, Shaker M
Therapeutics and Clinical Risk Management 2015, 11:279-288
Published Date: 19 February 2015
Antithrombotic therapy for long-term secondary prevention of acute coronary syndrome in high-risk patients
Husted S
Therapeutics and Clinical Risk Management 2015, 11:263-277
Published Date: 17 February 2015
Factors that increase external pressure to the fibular head region, but not medial region, during use of a knee-crutch/leg-holder system in the lithotomy position
Mizuno J, Takahashi T
Therapeutics and Clinical Risk Management 2015, 11:255-261
Published Date: 16 February 2015
Reducing drug–herb interaction risk with a computerized reminder system
Lin SS, Tsai CL, Tu CY, Hsieh CL
Therapeutics and Clinical Risk Management 2015, 11:247-253
Published Date: 16 February 2015
PSCA rs2294008 C > T polymorphism contributes to gastric and bladder cancer risk
Wang M, Wang XJ, Ma YF, Ma XB, Dai ZM, Lv Y, Lin S, Liu XH, Yang PT, Dai ZJ
Therapeutics and Clinical Risk Management 2015, 11:237-245
Published Date: 13 February 2015
Serum hepatitis B surface antigen titer and transient elastography in screening for insignificant fibrosis in HBeAg-positive chronic hepatitis B patients
Liang LB, Zhu X, Yan LB, Du LY, Liu C, Chen LY, Liao J, Tang H
Therapeutics and Clinical Risk Management 2015, 11:229-235
Published Date: 13 February 2015
Travel advice for the immunocompromised traveler: prophylaxis, vaccination, and other preventive measures
Patel RR, Liang SY, Koolwal P, Kuhlmann FM
Therapeutics and Clinical Risk Management 2015, 11:217-228
Published Date: 12 February 2015
Pain-to-hospital times, cardiovascular risk factors, and early intrahospital mortality in patients with acute myocardial infarction
Brković E, Novak K, Puljak L
Therapeutics and Clinical Risk Management 2015, 11:209-216
Published Date: 11 February 2015
Current status of parenteral nutrition and enteral nutrition application: an assessment of nutritional prescriptions from 59 hospitals in the People’s Republic of China
Han G, Yu ZW, Ma K
Therapeutics and Clinical Risk Management 2015, 11:201-207
Published Date: 10 February 2015
Echocardiographic assessment of left ventricular function in thyrotoxicosis and implications for the therapeutics of thyrotoxic cardiac disease
Anakwue RC, Onwubere BJ, Ikeh V, Anisiuba B, Ike S, Anakwue AC
Therapeutics and Clinical Risk Management 2015, 11:189-200
Published Date: 5 February 2015
Xerostomia induced by radiotherapy: an overview of the physiopathology, clinical evidence, and management of the oral damage
Pinna R, Campus G, Cumbo E, Mura I, Milia E
Therapeutics and Clinical Risk Management 2015, 11:171-188
Published Date: 4 February 2015
Anterior cervical discectomy and fusion versus anterior cervical corpectomy and fusion in the treatment of multilevel cervical spondylotic myelopathy: systematic review and a meta-analysis
Wen ZQ, Du JY, Ling ZH, Xu HD, Lin XJ
Therapeutics and Clinical Risk Management 2015, 11:161-170
Published Date: 29 January 2015
Peripherally inserted central catheter thrombosis incidence and risk factors in cancer patients: a double-center prospective investigation
Liu Y, Gao Y, Wei L, Chen W, Ma X, Song L
Therapeutics and Clinical Risk Management 2015, 11:153-160
Published Date: 29 January 2015
Alpha-1 proteinase inhibitors for the treatment of alpha-1 antitrypsin deficiency: safety, tolerability, and patient outcomes
Chotirmall SH, Al-Alawi M, McEnery T, McElvaney NG
Therapeutics and Clinical Risk Management 2015, 11:143-151
Published Date: 29 January 2015
Comparative efficacy and safety of local and systemic methotrexate injection in cesarean scar pregnancy
Peng P, Gui T, Liu X, Chen W, Liu Z
Therapeutics and Clinical Risk Management 2015, 11:137-142
Published Date: 27 January 2015
Statin therapy in patients with acute coronary syndrome: low-density lipoprotein cholesterol goal attainment and effect of statin potency
Chinwong D, Patumanond J, Chinwong S, Siriwattana K, Gunaparn S, Hall JJ, Phrommintikul A
Therapeutics and Clinical Risk Management 2015, 11:127-136
Published Date: 23 January 2015
Neural circuits in anxiety and stress disorders: a focused review
Duval ER, Javanbakht A, Liberzon I
Therapeutics and Clinical Risk Management 2015, 11:115-126
Published Date: 23 January 2015
Target-controlled infusion and population pharmacokinetics of landiolol hydrochloride in patients with peripheral arterial disease
Kunisawa T, Yamagishi A, Suno M, Nakade S, Honda N, Kurosawa A, Sugawara A, Tasaki Y, Iwasaki H
Therapeutics and Clinical Risk Management 2015, 11:107-114
Published Date: 17 January 2015
Tapentadol extended release in the management of peripheral diabetic neuropathic pain
Vadivelu N, Kai A, Maslin B, Kodumudi G, Legler A, Berger JM
Therapeutics and Clinical Risk Management 2015, 11:95-105
Published Date: 14 January 2015
Prognostic role of serum C-reactive protein in esophageal cancer: a systematic review and meta-analysis
Huang Y, Feng JF, Liu JS, Chen QX
Therapeutics and Clinical Risk Management 2015, 11:89-94
Published Date: 14 January 2015
Effect of combination tablets containing amlodipine 10 mg and irbesartan 100 mg on blood pressure and cardiovascular risk factors in patients with hypertension
Yagi S, Takashima A, Mitsugi M, Wada T, Hotchi J, Aihara K, Hara T, Ishida M, Fukuda D, Ise T, Yamaguchi K, Tobiume T, Iwase T, Yamada H, Soeki T, Wakatsuki T, Shimabukuro M, Akaike M, Sata M
Therapeutics and Clinical Risk Management 2015, 11:83-88
Published Date: 12 January 2015
Management of bipolar I depression: clinical utility of lurasidone
Findlay LJ, El-Mallakh P, El-Mallakh RS
Therapeutics and Clinical Risk Management 2015, 11:75-81
Published Date: 8 January 2015
Biologics in the management of ulcerative colitis – comparative safety and efficacy of TNF-α antagonists
Fausel R, Afzali A
Therapeutics and Clinical Risk Management 2015, 11:63-73
Published Date: 5 January 2015
Rhegmatogenous retinal detachment due to a macular hole in a patient with pars planitis: a case report
Stavrakas P, Androu AA, Tranos P, Kontou E, Milia M, Georgalas I
Therapeutics and Clinical Risk Management 2015, 11:59-61
Published Date: 30 December 2014
The effect of nonsurgical periodontal treatment on serum and saliva chitotriosidase activities in patients with periodontitis and coronary artery disease
Bal MV, Olgun A, Abaslı D, Özdemir A. Kürşaklıoğlu H, Göktepe AS, Kurt Í
Therapeutics and Clinical Risk Management 2015, 11:53-58
Published Date: 30 December 2014
Diagnosis and management of xerostomia and hyposalivation
Villa A, Connell CL, Abati S
Therapeutics and Clinical Risk Management 2015, 11:45-51
Published Date: 22 December 2014
Treatment of adult-onset Still’s disease: a review
Jamilloux Y, Gerfaud-Valentin M, Henry T, Sève P
Therapeutics and Clinical Risk Management 2015, 11:33-43
Published Date: 22 December 2014
Effectiveness and safety of Humalog Mix 50/50 versus Humalog Mix 75/25 in Chinese patients with type 2 diabetes
Zafar MI, Ai X, Shafqat RA, Gao F
Therapeutics and Clinical Risk Management 2015, 11:27-32
Published Date: 19 December 2014
Bayesian imperfect information analysis for clinical recurrent data
Chang CK, Chang CC
Therapeutics and Clinical Risk Management 2015, 11:17-26
Published Date: 19 December 2014
Patient risk factors for developing a drug-related problem in a cardiology ward
Urbina O, Ferrández O, Luque S, Grau S, Mojal S, Pellicer R, Riu M, Salas E, Comin-Colet J
Therapeutics and Clinical Risk Management 2015, 11:9-15
Published Date: 17 December 2014
Prescriber utilization of dalfampridine extended release tablets in multiple sclerosis: a retrospective pharmacy and medical claims analysis
Jara M, Sidovar MF, Henney III HR
Therapeutics and Clinical Risk Management 2015, 11:1-7
Published Date: 16 December 2014